← Insider buys
CHRS

Coherus Oncology, Inc. · Healthcare

Director James Healy sold $6.8M of Coherus Oncology, Inc.

Sold$6,777,068
$21.37Price
317,130Shares
−12%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Thu, Jun 20. Filed Mon, Jun 24, 6:30 PM ET, after the close. Not investment advice.